|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
357,741,000 |
Market
Cap: |
133.31(B) |
Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
52
Week Range: |
$258.49 - $400.59 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
NASDAQ-100 |
|
S&P 400 MIDCAP |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 1071 |
Guru Rank Value : -4.4 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
24,974 |
280,973 |
411,250 |
790,845 |
Total Sell Value |
$9,676,524 |
$108,309,729 |
$148,037,804 |
$243,516,438 |
Total People Sold |
8 |
12 |
13 |
13 |
Total Sell Transactions |
20 |
41 |
56 |
83 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Rosa David J. |
EVP & Chief Commercial Officer |
|
2017-02-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(272) |
3,222 |
|
- |
|
Rosa David J. |
EVP & Chief Commercial Officer |
|
2017-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
521 |
3,494 |
|
- |
|
Samath Jamie |
VP & Principal Accounting Offi |
|
2017-02-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(98) |
538 |
|
- |
|
Samath Jamie |
VP & Principal Accounting Offi |
|
2017-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
260 |
636 |
|
- |
|
Guthart Gary S |
President & CEO |
|
2017-02-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(327) |
70,573 |
|
- |
|
Guthart Gary S |
President & CEO |
|
2017-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
625 |
70,900 |
|
- |
|
Myriam Curet |
SVP & Chief Medical OfficerSVP |
|
2017-02-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(195) |
984 |
|
- |
|
Myriam Curet |
SVP & Chief Medical OfficerSVP |
|
2017-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
417 |
1,179 |
|
- |
|
Brogna Salvatore |
EVP - Product Operations |
|
2017-02-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(272) |
1,584 |
|
- |
|
Brogna Salvatore |
EVP - Product Operations |
|
2017-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
521 |
1,856 |
|
- |
|
Mohr Marshall |
SVP & CFO |
|
2017-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(368) |
1,923 |
|
- |
|
Mohr Marshall |
SVP & CFO |
|
2017-02-17 |
4 |
AS |
$725.00 |
$1,450,000 |
D/D |
(2,000) |
2,291 |
|
- |
|
Mohr Marshall |
SVP & CFO |
|
2017-02-17 |
4 |
OE |
$0.00 |
$606,540 |
D/D |
2,704 |
4,291 |
|
- |
|
Meltzer Mark J |
SVP General Counsel & CCO |
|
2017-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(217) |
2,057 |
|
- |
|
Meltzer Mark J |
SVP General Counsel & CCO |
|
2017-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
569 |
2,274 |
|
- |
|
Rosa David J. |
EVP & Chief Commercial Officer |
|
2017-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(396) |
2,973 |
|
- |
|
Rosa David J. |
EVP & Chief Commercial Officer |
|
2017-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
758 |
3,369 |
|
- |
|
Samath Jamie |
VP & Principal Accounting Offi |
|
2017-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(92) |
376 |
|
- |
|
Samath Jamie |
VP & Principal Accounting Offi |
|
2017-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
244 |
468 |
|
- |
|
Guthart Gary S |
President & CEO |
|
2017-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(453) |
70,275 |
|
- |
|
Guthart Gary S |
President & CEO |
|
2017-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
867 |
70,728 |
|
- |
|
Myriam Curet |
SVP & Chief Medical OfficerSVP |
|
2017-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(163) |
762 |
|
- |
|
Myriam Curet |
SVP & Chief Medical OfficerSVP |
|
2017-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
433 |
925 |
|
- |
|
Brogna Salvatore |
EVP - Product Operations |
|
2017-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(396) |
1,335 |
|
- |
|
Brogna Salvatore |
EVP - Product Operations |
|
2017-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
758 |
1,731 |
|
- |
|
1324 Records found
|
|
Page 40 of 53 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|